Literature DB >> 22084457

Prophylactic use of antimalarials during pregnancy.

Marie-Hélène Irvine1, Adrienne Einarson, Pina Bozzo.   

Abstract

QUESTION: Some of my pregnant patients wish to travel to malaria-endemic regions. Are there medications that can be used safely during pregnancy for malaria prophylaxis? ANSWER: Pregnant women should avoid travel to malaria-endemic areas if possible. However, if travel cannot be avoided, measures to prevent mosquito bites, along with an effective chemoprophylaxis regimen, should be implemented. Chloroquine or hydroxychloroquine are considered safe to use in all trimesters of pregnancy. Mefloquine is the agent of choice for chloroquine-resistant areas, and evidence suggests it is not associated with an increased risk to the fetus. Although the atovaquone-proguanil drug combination is not currently recommended for use during pregnancy, limited data suggest that it is not harmful to the fetus. Doxycycline and primaquine are not recommended during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22084457      PMCID: PMC3215604     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  17 in total

1.  Alternatives for malaria prophylaxis during the first trimester of pregnancy: our personal view.

Authors:  Urban Hellgren; Lars Rombo
Journal:  J Travel Med       Date:  2010 Mar-Apr       Impact factor: 8.490

2.  Canadian recommendations for the prevention and treatment of malaria among international travellers--2009.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2009-07

3.  Atovaquone-proguanil use in early pregnancy and the risk of birth defects.

Authors:  Björn Pasternak; Anders Hviid
Journal:  Arch Intern Med       Date:  2011-02-14

4.  A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.

Authors:  Rose McGready; Elizabeth A Ashley; Eh Moo; Thein Cho; Marion Barends; Robert Hutagalung; Sornchai Looareesuwan; Nicholas J White; François Nosten
Journal:  J Infect Dis       Date:  2005-07-27       Impact factor: 5.226

5.  The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.

Authors:  K Na-Bangchang; C Manyando; R Ruengweerayut; D Kioy; M Mulenga; G B Miller; J Konsil
Journal:  Eur J Clin Pharmacol       Date:  2005-07-23       Impact factor: 2.953

Review 6.  Primaquine therapy for malaria.

Authors:  J Kevin Baird; Stephen L Hoffman
Journal:  Clin Infect Dis       Date:  2004-10-12       Impact factor: 9.079

Review 7.  Importance and prevention of malaria in pregnancy.

Authors:  Caroline E Shulman; Edgar K Dorman
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Jan-Feb       Impact factor: 2.184

8.  Safety of chloroquine in chemosuppression of malaria during pregnancy.

Authors:  M S Wolfe; J F Cordero
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

9.  Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.

Authors:  Rose McGready; Napaporn Khan Keo; Leopoldo Villegas; Nicholas J White; Sornchai Looareesuwan; François Nosten
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Sep-Oct       Impact factor: 2.184

10.  The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.

Authors:  R McGready; K Stepniewska; M D Edstein; T Cho; G Gilveray; S Looareesuwan; N J White; F Nosten
Journal:  Eur J Clin Pharmacol       Date:  2003-08-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.